Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis.
Creemers, A
Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis. [electronic resource] - Scientific reports 06 2017 - 3135 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
2045-2322
10.1038/s41598-017-03304-9 doi
Adenocarcinoma--drug therapy
Antineoplastic Agents--therapeutic use
Esophageal Neoplasms--drug therapy
Gene Amplification
Humans
Neoplasm Metastasis
Receptor, ErbB-2--metabolism
Stomach Neoplasms--drug therapy
Trastuzumab--therapeutic use
Treatment Outcome
Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis. [electronic resource] - Scientific reports 06 2017 - 3135 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
2045-2322
10.1038/s41598-017-03304-9 doi
Adenocarcinoma--drug therapy
Antineoplastic Agents--therapeutic use
Esophageal Neoplasms--drug therapy
Gene Amplification
Humans
Neoplasm Metastasis
Receptor, ErbB-2--metabolism
Stomach Neoplasms--drug therapy
Trastuzumab--therapeutic use
Treatment Outcome